Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
This report aims to provide a comprehensive presentation of the global market for Ovarian Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Cancer. This report contains market size and forecasts of Ovarian Cancer in global, including the following market information:
Global Ovarian Cancer Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Ovarian Cancer market was valued at US$ 1800.7 million in 2022 and is projected to reach US$ 3311.2 million by 2035, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
We surveyed the Ovarian Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ovarian Cancer Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Ovarian Cancer Market Segment Percentages, by Type, 2022 (%)
Surgery
Chemotherapy
Radiation
Biological Therapy
Global Ovarian Cancer Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Ovarian Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Ovarian Cancer Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Ovarian Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ovarian Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ovarian Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ovarian Cancer, market overview.
Chapter 2: Global Ovarian Cancer market size in revenue.
Chapter 3: Detailed analysis of Ovarian Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ovarian Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ovarian Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ovarian Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ovarian Cancer Overall Market Size
2.1 Global Ovarian Cancer Market Size: 2022 VS 2035
2.2 Global Ovarian Cancer Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ovarian Cancer Players in Global Market
3.2 Top Global Ovarian Cancer Companies Ranked by Revenue
3.3 Global Ovarian Cancer Revenue by Companies
3.4 Top 3 and Top 5 Ovarian Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ovarian Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ovarian Cancer Players in Global Market
3.6.1 List of Global Tier 1 Ovarian Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Ovarian Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ovarian Cancer Market Size Markets, 2022 & 2035
4.1.2 Surgery
4.1.3 Chemotherapy
4.1.4 Radiation
4.1.5 Biological Therapy
4.2 By Type - Global Ovarian Cancer Revenue & Forecasts
4.2.1 By Type - Global Ovarian Cancer Revenue, 2018-2023
4.2.2 By Type - Global Ovarian Cancer Revenue, 2024-2035
4.2.3 By Type - Global Ovarian Cancer Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ovarian Cancer Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Ovarian Cancer Revenue & Forecasts
5.2.1 By Application - Global Ovarian Cancer Revenue, 2018-2023
5.2.2 By Application - Global Ovarian Cancer Revenue, 2024-2035
5.2.3 By Application - Global Ovarian Cancer Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Ovarian Cancer Market Size, 2022 & 2035
6.2 By Region - Global Ovarian Cancer Revenue & Forecasts
6.2.1 By Region - Global Ovarian Cancer Revenue, 2018-2023
6.2.2 By Region - Global Ovarian Cancer Revenue, 2024-2035
6.2.3 By Region - Global Ovarian Cancer Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Ovarian Cancer Revenue, 2018-2035
6.3.2 US Ovarian Cancer Market Size, 2018-2035
6.3.3 Canada Ovarian Cancer Market Size, 2018-2035
6.3.4 Mexico Ovarian Cancer Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Ovarian Cancer Revenue, 2018-2035
6.4.2 Germany Ovarian Cancer Market Size, 2018-2035
6.4.3 France Ovarian Cancer Market Size, 2018-2035
6.4.4 U.K. Ovarian Cancer Market Size, 2018-2035
6.4.5 Italy Ovarian Cancer Market Size, 2018-2035
6.4.6 Russia Ovarian Cancer Market Size, 2018-2035
6.4.7 Nordic Countries Ovarian Cancer Market Size, 2018-2035
6.4.8 Benelux Ovarian Cancer Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Ovarian Cancer Revenue, 2018-2035
6.5.2 China Ovarian Cancer Market Size, 2018-2035
6.5.3 Japan Ovarian Cancer Market Size, 2018-2035
6.5.4 South Korea Ovarian Cancer Market Size, 2018-2035
6.5.5 Southeast Asia Ovarian Cancer Market Size, 2018-2035
6.5.6 India Ovarian Cancer Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Ovarian Cancer Revenue, 2018-2035
6.6.2 Brazil Ovarian Cancer Market Size, 2018-2035
6.6.3 Argentina Ovarian Cancer Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ovarian Cancer Revenue, 2018-2035
6.7.2 Turkey Ovarian Cancer Market Size, 2018-2035
6.7.3 Israel Ovarian Cancer Market Size, 2018-2035
6.7.4 Saudi Arabia Ovarian Cancer Market Size, 2018-2035
6.7.5 UAE Ovarian Cancer Market Size, 2018-2035
7 Ovarian Cancer Companies Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Ovarian Cancer Major Product Offerings
7.1.4 Bristol Myers Squibb Ovarian Cancer Revenue in Global Market (2018-2023)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Ovarian Cancer Major Product Offerings
7.2.4 Eli Lilly Ovarian Cancer Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Ovarian Cancer Major Product Offerings
7.3.4 GlaxoSmithKline Ovarian Cancer Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Company Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Ovarian Cancer Major Product Offerings
7.4.4 Janssen Pharmaceuticals Ovarian Cancer Revenue in Global Market (2018-2023)
7.4.5 Janssen Pharmaceuticals Key News & Latest Developments
7.5 Novogen
7.5.1 Novogen Company Summary
7.5.2 Novogen Business Overview
7.5.3 Novogen Ovarian Cancer Major Product Offerings
7.5.4 Novogen Ovarian Cancer Revenue in Global Market (2018-2023)
7.5.5 Novogen Key News & Latest Developments
7.6 Genentech
7.6.1 Genentech Company Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Ovarian Cancer Major Product Offerings
7.6.4 Genentech Ovarian Cancer Revenue in Global Market (2018-2023)
7.6.5 Genentech Key News & Latest Developments
7.7 Aetera Zenteris
7.7.1 Aetera Zenteris Company Summary
7.7.2 Aetera Zenteris Business Overview
7.7.3 Aetera Zenteris Ovarian Cancer Major Product Offerings
7.7.4 Aetera Zenteris Ovarian Cancer Revenue in Global Market (2018-2023)
7.7.5 Aetera Zenteris Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Ovarian Cancer Major Product Offerings
7.8.4 Boehringer Ingelheim Ovarian Cancer Revenue in Global Market (2018-2023)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Ovarian Cancer Major Product Offerings
7.9.4 Roche Ovarian Cancer Revenue in Global Market (2018-2023)
7.9.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ovarian Cancer Market Opportunities & Trends in Global Market
Table 2. Ovarian Cancer Market Drivers in Global Market
Table 3. Ovarian Cancer Market Restraints in Global Market
Table 4. Key Players of Ovarian Cancer in Global Market
Table 5. Top Ovarian Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ovarian Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ovarian Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ovarian Cancer Product Type
Table 9. List of Global Tier 1 Ovarian Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ovarian Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ovarian Cancer Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Ovarian Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ovarian Cancer Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Ovarian Cancer Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Ovarian Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ovarian Cancer Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Ovarian Cancer Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Ovarian Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ovarian Cancer Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Ovarian Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ovarian Cancer Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Ovarian Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ovarian Cancer Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Ovarian Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ovarian Cancer Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Ovarian Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ovarian Cancer Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Ovarian Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ovarian Cancer Revenue, (US$, Mn), 2024-2035
Table 30. Bristol Myers Squibb Company Summary
Table 31. Bristol Myers Squibb Ovarian Cancer Product Offerings
Table 32. Bristol Myers Squibb Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol Myers Squibb Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Ovarian Cancer Product Offerings
Table 36. Eli Lilly Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Ovarian Cancer Product Offerings
Table 40. GlaxoSmithKline Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Janssen Pharmaceuticals Company Summary
Table 43. Janssen Pharmaceuticals Ovarian Cancer Product Offerings
Table 44. Janssen Pharmaceuticals Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Janssen Pharmaceuticals Key News & Latest Developments
Table 46. Novogen Company Summary
Table 47. Novogen Ovarian Cancer Product Offerings
Table 48. Novogen Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Novogen Key News & Latest Developments
Table 50. Genentech Company Summary
Table 51. Genentech Ovarian Cancer Product Offerings
Table 52. Genentech Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Genentech Key News & Latest Developments
Table 54. Aetera Zenteris Company Summary
Table 55. Aetera Zenteris Ovarian Cancer Product Offerings
Table 56. Aetera Zenteris Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Aetera Zenteris Key News & Latest Developments
Table 58. Boehringer Ingelheim Company Summary
Table 59. Boehringer Ingelheim Ovarian Cancer Product Offerings
Table 60. Boehringer Ingelheim Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Ovarian Cancer Product Offerings
Table 64. Roche Ovarian Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Roche Key News & Latest Developments
List of Figures
Figure 1. Ovarian Cancer Segment by Type in 2022
Figure 2. Ovarian Cancer Segment by Application in 2022
Figure 3. Global Ovarian Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ovarian Cancer Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Ovarian Cancer Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ovarian Cancer Revenue in 2022
Figure 8. By Type - Global Ovarian Cancer Revenue Market Share, 2018-2035
Figure 9. By Application - Global Ovarian Cancer Revenue Market Share, 2018-2035
Figure 10. By Type - Global Ovarian Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Ovarian Cancer Revenue Market Share, 2018-2035
Figure 12. By Application - Global Ovarian Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Ovarian Cancer Revenue Market Share, 2018-2035
Figure 14. By Region - Global Ovarian Cancer Revenue Market Share, 2018-2035
Figure 15. By Country - North America Ovarian Cancer Revenue Market Share, 2018-2035
Figure 16. US Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Ovarian Cancer Revenue Market Share, 2018-2035
Figure 20. Germany Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 21. France Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Ovarian Cancer Revenue Market Share, 2018-2035
Figure 28. China Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 32. India Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Ovarian Cancer Revenue Market Share, 2018-2035
Figure 34. Brazil Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Ovarian Cancer Revenue Market Share, 2018-2035
Figure 37. Turkey Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Ovarian Cancer Revenue, (US$, Mn), 2018-2035
Figure 41. Bristol Myers Squibb Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Janssen Pharmaceuticals Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novogen Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Genentech Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aetera Zenteris Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boehringer Ingelheim Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roche Ovarian Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
